FDA Announces New Label Warnings on Opioid Medications

The U.S. Food and Drug Administration (FDA) has announced new  requirements for safety labeling on immediate-release (IR) opioid pain medications such as oxycodone, hydrocodone and morphine. These changes are FDA’s latest action in its Action Plan to address the growing epidemic of opioid abuse in the United States, and is another “wake up call” to prescribers that the US Government is closely scrutinizing the prescription of opiates.

For more information regarding these new requirements, please click here to read our Client Alert.

If you have any questions, please contact the GW attorney with whom you regularly consult.